Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.08%15.09B | -1.86%63.35B | 4.20%15.73B | 10.49%64.55B | 10.75%16.38B | 8.04%17.21B | 15.00%15.87B | 8.55%15.1B | 5.94%58.42B | 8.74%14.79B |
| Cost of revenue | -1.51%11.83B | 1.64%49.08B | 5.03%12.01B | 10.42%48.29B | 8.33%12.25B | 8.44%12.53B | 12.21%12.08B | 13.13%11.43B | 9.14%43.73B | 13.54%11.3B |
| Gross profit | -12.38%3.26B | -12.25%14.27B | 1.61%3.73B | 10.70%16.26B | 18.59%4.13B | 7.03%4.68B | 24.93%3.79B | -3.65%3.67B | -2.56%14.69B | -4.34%3.49B |
| Operating expense | -6.34%2.88B | 3.32%11.89B | 11.21%3.08B | 7.11%11.51B | 11.47%3.05B | 2.24%2.88B | 7.25%2.81B | 7.67%2.77B | 8.95%10.74B | 8.44%2.74B |
| Operating profit | -40.92%384M | -49.91%2.38B | -27.86%650M | 20.46%4.76B | 44.65%1.08B | 15.74%1.79B | 136.71%980M | -27.16%901M | -24.31%3.95B | -33.15%748M |
| Net non-operating interest income (expenses) | -62.99%57M | 4.38%643M | 58.76%154M | 138.76%616M | 102.70%225M | 91.14%151M | 308.57%143M | 193.94%97M | 84.29%258M | 88.14%111M |
| Non-operating interest income | -30.82%110M | 4.45%657M | 60.61%159M | 127.08%629M | 86.99%230M | 97.44%154M | 265.00%146M | 175.00%99M | 87.16%277M | 101.64%123M |
| Non-operating interest expense | 960.00%53M | 7.69%14M | 150.00%5M | -31.58%13M | -58.33%5M | 400.00%3M | -40.00%3M | -33.33%2M | 137.50%19M | 500.00%12M |
| Net investment income | 3,500.00%102M | 51.53%-111M | 91.18%-3M | 3.78%-229M | -77.42%-55M | 76.54%-19M | -116.07%-121M | 51.43%-34M | -128.85%-238M | 68.04%-31M |
| Gain(Loss) on financial instruments designated as cash flow hedges | -750.00%-17M | 81.82%-2M | 10M | -11M | ||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -97.25%3M | 2,080.00%109M | 5M | |||||||
| Income from associates and other participating interests | 0 | -43.27%316M | -19.28%134M | -19.04%557M | -165.83%-131M | 138.51%353M | 3.05%169M | -6.21%166M | -10.53%688M | 0.51%199M |
| Special income (charges) | -211M | 82.95%-15M | 0 | 45.34%-88M | 62.10%-47M | -825.00%-29M | 70.27%-11M | 75.00%-1M | 36.11%-161M | -143.14%-124M |
| Less:Restructuring and mergern&acquisition | --210M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | --1M | -28.57%15M | ---- | -58.00%21M | -93.62%3M | 250.00%6M | 266.67%11M | -75.00%1M | -28.57%50M | -7.84%47M |
| Less:Write off | ---- | --0 | ---- | -39.64%67M | -42.86%44M | ---- | ---- | ---- | -39.01%111M | --77M |
| Other non-operating income (expenses) | -522.86%-218M | 235.04%185M | -25.00%-35M | -153.73%-137M | -657.89%-432M | 29.71%227M | 12.94%96M | -153.85%-28M | 304.00%255M | 75.32%-57M |
| Income before tax | -89.30%96M | -39.05%3.4B | -17.63%897M | 17.37%5.58B | -12.08%750M | 32.16%2.48B | 109.09%1.27B | -23.47%1.09B | -14.98%4.76B | -10.12%853M |
| Income tax | -118.52%-30M | 3.61%1.55B | 113.16%162M | 16.34%1.5B | 104.01%610M | 29.33%538M | 22.07%271M | -78.16%76M | -1.31%1.29B | -13.83%299M |
| Net income | -82.83%126M | -54.69%1.85B | -27.54%734M | 17.75%4.09B | -74.55%141M | 32.97%1.94B | 159.27%993M | -5.77%1.01B | -19.13%3.47B | -8.13%554M |
| Net income continuous operations | -82.86%126M | -54.66%1.85B | -27.44%735M | 17.75%4.09B | -74.73%140M | 32.97%1.94B | 159.53%994M | -5.77%1.01B | -19.13%3.47B | -7.97%554M |
| Noncontrolling interests | -107.69%-1M | -18.92%60M | -7.14%13M | -22.92%74M | -35.42%31M | -40.00%18M | 83.33%11M | 16.67%14M | 41.18%96M | 300.00%48M |
| Net income attributable to the company | -82.25%128M | -55.35%1.79B | -27.83%721M | 18.90%4.01B | -78.30%110M | 34.57%1.92B | 160.90%981M | -6.02%999M | -20.10%3.38B | -14.21%507M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -82.25%128M | -55.35%1.79B | -27.83%721M | 18.90%4.01B | -78.30%110M | 34.57%1.92B | 160.90%981M | -6.02%999M | -20.10%3.38B | -14.21%507M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -78.05%4.65 | -55.32%52.67 | -27.84%21.18 | 18.89%117.88 | -78.43%3.21 | 34.56%56.49 | 160.67%28.83 | -6.02%29.35 | -18.54%99.15 | -14.87%14.88 |
| Diluted earnings per share | -78.05%4.65 | -55.32%52.67 | -27.84%21.18 | 18.89%117.88 | -78.43%3.21 | 34.56%56.4879 | 160.89%28.8167 | -6.02%29.35 | -18.54%99.15 | -14.29%14.88 |
| Dividend per share | 0 | -22.03%92 | 0 | 18.00%118 | 3.51%59 | 0 | 37.21%59 | 0 | 122.22%100 | 153.33%57 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |